Search

Your search keyword '"Glasspool, Ros"' showing total 3 results
Start Over Author "Glasspool, Ros" Topic clinical trials as topic
3 results on '"Glasspool, Ros"'

1. European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners--First Update 2015.

Author

du Bois A, Reuss A, Pujade-Lauraine E, Pignata S, Ledermann J, Casado A, Sehouli J, Mirza M, Colombo N, Marth C, Witteveen E, Del Campo J, Calvert P, Aravantinos G, Vardar MA, van der Zee AG, Korach J, Taskiran C, Fehr M, Glasspool R, Pfisterer J, Cibula D, and Vergote I

Subjects
European Union, Humans, Academic Medical Centers, Clinical Trials as Topic standards, Drug Industry, Guidelines as Topic, Gynecology standards, Medical Oncology standards
Abstract

The first version of ENGOT's Requirements for Trials Between Academic Groups and Industry Partners in Europe was published 2010. This first update integrates the experiences made by the ENGOT network and the cooperative group studies while performing, analyzing, and publishing -among others - three large phase III trials. Furthermore, progress in European legislation and its impact on clinical studies in Europe have been considered in this update process.

Published
2015
Full Text
View/download PDF

2. The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership.

Author

Marth C, du Bois A, Schauer C, du Bois A, Casado A, Vergote I, del Campo JM, Goudopoulou A, Pujade-Lauraine E, Bruchim I, Colombo N, Pignata S, Ledermann J, Chekerov R, Raza Mirza M, Westermann A, Glasspool R, Taskiran C, Fehr M, and Cibula D

Subjects
Female, Guidelines as Topic, Humans, Clinical Trials as Topic standards, European Union, Gynecology standards, Medical Oncology standards, Public-Private Sector Partnerships organization & administration
Published
2015
Full Text
View/download PDF

3. Clinical trials in recurrent ovarian cancer.

Author

Friedlander M, Trimble E, Tinker A, Alberts D, Avall-Lundqvist E, Brady M, Harter P, Pignata S, Pujade-Lauraine E, Sehouli J, Vergote I, Beale P, Bekkers R, Calvert P, Copeland L, Glasspool R, Gonzalez-Martin A, Katsaros D, Kim JW, Miller B, Provencher D, Rubinstein L, Atri M, Zeimet A, Bacon M, Kitchener H, and Stuart GC

Subjects
Carcinoma pathology, Clinical Trials as Topic trends, Consensus, Endpoint Determination methods, Female, Gynecologic Surgical Procedures methods, Gynecologic Surgical Procedures trends, Humans, Neoadjuvant Therapy, Ovarian Neoplasms pathology, Recurrence, Carcinoma therapy, Clinical Trials as Topic methods, Ovarian Neoplasms therapy
Abstract

The 4th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup was held in Vancouver, Canada, in June 2010. Representatives of 23 cooperative research groups studying gynecologic cancers gathered to establish international consensus on issues critical to the conduct of large randomized trials. Group C, 1 of the 3 discussion groups, examined recurrent ovarian cancer, and we report the consensus reached regarding 4 questions. These included the following: (1) What is the role of cytoreductive surgery for recurrent ovarian cancer? (2) How do we define distinct patient populations in need of specific therapeutic approaches? (3) Should end points for trials with recurrent disease vary from those of first-line trials? (4) Is CA-125 progression alone sufficient for entry/eligibility into clinical trials?

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results